Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-Deficiency
NCT07361263
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
28
Enrollment
OTHER
Sponsor class
Conditions
AVP Deficiency
Diabetes Insipidus
Interventions
DRUG:
estradiol valerate
DRUG:
esthinylestradiol
Sponsor
University Hospital, Basel, Switzerland